Here's a link to the Morgan's Healthcare weekly round up.
https://soundcloud.com/morgans-financial-limited/under-the-microscope-wrap-week-ending-22-november-2019
Friday's fall was most likely on the back of NAN being mentioned as part of a overvalued cohort of biotech stocks at the Sohn Hearts & Minds conference. Passive ETF's usually have algo's built in which react to certain "key words" and I think the selling was mainly an ETF dump. These types of sell downs provide an excellent opportunity for professional active investors to step up and get their fill.
I agree with the analyst's at Morgan's that the market has elected to look past the delay in the launch of the new product.
It's a structural growth business with a very large addressable market. Great management team with strong track record who are reinvesting heavily into pivot into different markets.
I think someone mentioned this in an earlier post, but the best way to look at NAN and the investment thesis is over a 5 years period. Believe there will be some great returns available for shareholders.
- Forums
- ASX - By Stock
- result
Here's a link to the Morgan's Healthcare weekly round...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NAN (ASX) to my watchlist
|
|||||
Last
$3.03 |
Change
0.020(0.66%) |
Mkt cap ! $918.0M |
Open | High | Low | Value | Volume |
$2.98 | $3.08 | $2.97 | $3.793M | 1.254M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 4405 | $3.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.03 | 8612 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5101 | 3.010 |
3 | 5102 | 3.000 |
1 | 1102 | 2.990 |
4 | 4137 | 2.980 |
2 | 1272 | 2.970 |
Price($) | Vol. | No. |
---|---|---|
3.040 | 1102 | 1 |
3.050 | 1102 | 1 |
3.060 | 1102 | 1 |
3.070 | 12102 | 3 |
3.080 | 1055 | 1 |
Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
Featured News
NAN (ASX) Chart |